An Emerging Role for Long Non-coding RNAs in Cancer Metastasis

Overview

Journal Front Genet

Date 2014 Aug 8

PMID 25101115

Citations 62

Authors

Jason T Serviss

Per Johnsson

Dan Grander

Affiliations

Soon will be listed here.

Abstract

Metastasis is a multistep process beginning with the dissemination of tumor cells from a primary site and leading to secondary tumor development in an anatomically distant location. Although significant progress has been made in understanding the molecular characteristics of metastasis, many questions remain regarding the intracellular mechanisms governing transition through the various metastatic stages. Long non-coding RNAs (lncRNAs) are capable of modulating both transcriptional and post-transcriptional regulation, and thus, coordinating a wide array of diverse cellular processes. Current evidence indicates that lncRNAs may also play a crucial role in the metastatic process through regulation of metastatic signaling cascades as well as interaction with specific metastatic factors. Here we summarize a subset of lncRNAs with proposed roles in metastasis and, when applicable, highlight the mechanism by which they function.

Citing Articles

Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.

Dong Y, Wen W, Yuan T, Liu L, Li X Dis Markers. 2023; 2023:1766080.

PMID: 36817087 PMC: 9936453. DOI: 10.1155/2023/1766080.

HEIH Promotes Malignant Progression of Gastric Cancer by Regulating STAT3-Mediated Autophagy and Glycolysis.

Zhang H, Shen X, Xiong S, Peng L, Mai W, Xin L Dis Markers. 2022; 2022:2634526.

PMID: 36246567 PMC: 9568361. DOI: 10.1155/2022/2634526.

Identification of Colon Cancer-Related RNAs Based on Heterogeneous Networks and Random Walk.

Chen B, Wang T, Zhang J, Zhang S, Shang X Biology (Basel). 2022; 11(7).

PMID: 36101384 PMC: 9312154. DOI: 10.3390/biology11071003.

Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials.

Khan A, Zhang X Bioengineering (Basel). 2022; 9(8).

PMID: 36004931 PMC: 9405066. DOI: 10.3390/bioengineering9080406.

Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System.

Li X, Wang X, Liu N, Wang Q, Hu J Molecules. 2022; 27(7).

PMID: 35408480 PMC: 9000533. DOI: 10.3390/molecules27072082.

References

Onyango P, Feinberg A . A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript. Proc Natl Acad Sci U S A. 2011; 108(40):16759-64. PMC: 3189046. DOI: 10.1073/pnas.1110904108. View

Davis I, Hsi B, Arroyo J, Vargas S, Yeh Y, Motyckova G . Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci U S A. 2003; 100(10):6051-6. PMC: 156324. DOI: 10.1073/pnas.0931430100. View

Ozsolak F, Milos P . RNA sequencing: advances, challenges and opportunities. Nat Rev Genet. 2010; 12(2):87-98. PMC: 3031867. DOI: 10.1038/nrg2934. View

Johnsson P, Ackley A, Vidarsdottir L, Lui W, Corcoran M, Grander D . A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol. 2013; 20(4):440-6. PMC: 3618526. DOI: 10.1038/nsmb.2516. View

Menghi F, Jacques T, Barenco M, Schwalbe E, Clifford S, Hubank M . Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development. Cancer Res. 2011; 71(6):2045-55. PMC: 3060131. DOI: 10.1158/0008-5472.CAN-10-2519. View

Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J . Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002; 23(11):1885-95. DOI: 10.1093/carcin/23.11.1885. View

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

Ocana O, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S . Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012; 22(6):709-24. DOI: 10.1016/j.ccr.2012.10.012. View

Schultz N, Andersen K, Roslind A, Willenbrock H, Wojdemann M, Johansen J . Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index. World J Surg. 2012; 36(11):2699-707. DOI: 10.1007/s00268-012-1705-y. View

10.

Span P, Rao J, Oude Ophuis S, Lenders J, Sweep F, Wesseling P . Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma. Endocr Relat Cancer. 2011; 18(3):323-31. DOI: 10.1530/ERC-10-0184. View

11.

Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, de-Groot N . Possible physiological role of H19 RNA. Mol Carcinog. 2002; 35(2):63-74. DOI: 10.1002/mc.10075. View

12.

Brabletz T . To differentiate or not--routes towards metastasis. Nat Rev Cancer. 2012; 12(6):425-36. DOI: 10.1038/nrc3265. View

13.

Hu W, Alvarez-Dominguez J, Lodish H . Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep. 2012; 13(11):971-83. PMC: 3492712. DOI: 10.1038/embor.2012.145. View

14.

Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J . The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2(2):84-9. DOI: 10.1038/35000034. View

15.

Picelli S, Faridani O, Bjorklund A, Winberg G, Sagasser S, Sandberg R . Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc. 2014; 9(1):171-81. DOI: 10.1038/nprot.2014.006. View

16.

Bekri S, Adelaide J, Merscher S, Grosgeorge J, Caroli-Bosc F, Perucca-Lostanlen D . Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. Cytogenet Cell Genet. 1997; 79(1-2):125-31. DOI: 10.1159/000134699. View

17.

Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M . Antisense transcription in the mammalian transcriptome. Science. 2005; 309(5740):1564-6. DOI: 10.1126/science.1112009. View

18.

Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F . Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst. 2012; 8(9):2289-94. DOI: 10.1039/c2mb25070e. View

19.

Riaz M, Berns E, Sieuwerts A, Ruigrok-Ritstier K, de Weerd V, Groenewoud A . Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat. 2011; 133(3):843-51. DOI: 10.1007/s10549-011-1663-3. View

20.

Sanford J, Wang X, Mort M, VanDuyn N, Cooper D, Mooney S . Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. Genome Res. 2009; 19(3):381-94. PMC: 2661799. DOI: 10.1101/gr.082503.108. View